{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:25:56Z","timestamp":1790681156251,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,10,8]],"date-time":"2003-10-08T00:00:00Z","timestamp":1065571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,10,8]],"date-time":"2003-10-08T00:00:00Z","timestamp":1065571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1007\/s00277-003-0749-3","type":"journal-article","created":{"date-parts":[[2004,3,19]],"date-time":"2004-03-19T08:27:09Z","timestamp":1079684829000},"page":"198-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Herpes zoster during treatment with arsenic trioxide"],"prefix":"10.1007","volume":"83","author":[{"given":"T.","family":"Tanvetyanon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,8]]},"reference":[{"key":"749_CR1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.7326\/0003-4819-130-11-199906010-00017","volume":"130","author":"Cohen","year":"1999","unstructured":"Cohen JI, Brunell PA, Straus SE, Krause PR (1999) Recent advances in varicella-zoster virus infection. Ann Intern Med 130:922\u2013932","journal-title":"Ann Intern Med"},{"key":"749_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJMcp013211","volume":"347","author":"Gnann","year":"2002","unstructured":"Gnann JW Jr, Whitley RJ (2002) Herpes zoster. N Engl J Med 347:340\u2013346","journal-title":"N Engl J Med"},{"key":"749_CR3","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","volume":"19","author":"Soignet","year":"2001","unstructured":"Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, et al (2001) United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 19:3852\u20133860","journal-title":"J Clin Oncol"},{"key":"749_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1749-6632.1979.tb56630.x","volume":"320","author":"Seinen","year":"1979","unstructured":"Seinen W, Penninks A (1979) Immune suppression as a consequence of a selective cytotoxic activity of certain organometallic compounds on thymus and thymus-dependent lymphocytes. Ann N Y Acad Sci 320:499\u2013517","journal-title":"Ann N Y Acad Sci"},{"key":"749_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S1567-5769(00)00048-5","volume":"1","author":"Harrison","year":"2001","unstructured":"Harrison MT, McCoy KL (2001) Immunosuppression by arsenic: a comparison of cathepsin L inhibition and apoptosis. Int Immunopharmacol 1(4):647\u2013656","journal-title":"Int Immunopharmacol"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2249.2002.01885.x","volume":"129","author":"De","year":"2002","unstructured":"De la Fuente H, Portales-Perez D, Baranda L, Diaz-Barriga F, Saavedra-Alanis V, Layseca E, et al (2002) Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells. Clin Exp Immunol 129(1):69\u201377","journal-title":"Clin Exp Immunol"},{"key":"749_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1046\/j.1523-1747.2002.00475.x","volume":"119","author":"Yu","year":"2002","unstructured":"Yu HS, Liao WT, Chang KL, Yu CL, Chen GS (2002) Arsenic induces tumor necrosis factor alpha release and tumor necrosis factor receptor 1 signaling in T helper cell apoptosis. J Invest Dermatol 119(4):812\u2013819","journal-title":"J Invest Dermatol"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S1097-2765(01)00255-6","volume":"7","author":"Turelli","year":"2001","unstructured":"Turelli P, Doucas V, Craig E, Mangeat B, Klages N, Evans R, et al (2001) Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol Cell 7(6):1245\u20131254","journal-title":"Mol Cell"},{"key":"749_CR9","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1128\/JVI.77.5.3167-3180.2003","volume":"77","author":"Berthoux","year":"2003","unstructured":"Berthoux L, Towers GJ, Gurer C, Salomoni P, Pandolfi PP, Luban J (2003) As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J Virol 77(5):3167\u20133180","journal-title":"J Virol"},{"key":"749_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jnci\/90.2.124","volume":"90","author":"Shao","year":"1998","unstructured":"Shao W, Fanelli M, Ferrara FF et al (1998) Arsenic trioxide as an inducer of apoptosis and loss of PML\/RAR. \u03b1 protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124\u2013133","journal-title":"J Natl Cancer Inst"},{"key":"749_CR11","first-page":"3893","volume":"62","author":"Miller","year":"2002","unstructured":"Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S (2002) Mechanisms of action of arsenic trioxide. Cancer Res 62(14):3893\u20133903","journal-title":"Cancer Res"},{"key":"749_CR12","doi-asserted-by":"crossref","unstructured":"Waxman S, Anderson KC (2001) History of the development of arsenic derivatives in cancer therapy. Oncologist 6[Suppl\u00a02]: 3\u201310","DOI":"10.1634\/theoncologist.6-suppl_2-3"},{"key":"749_CR13","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1200\/JCO.2000.18.13.2620","volume":"18","author":"Camacho","year":"2000","unstructured":"Camacho LH, Soignet SL, Chanel S, et al (2000) Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide. J Clin Oncol 18:2620\u20132625","journal-title":"J Clin Oncol"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1182\/blood.V98.2.266","volume":"98","author":"Westervelt","year":"2001","unstructured":"Westervelt P, Brown RA, Adkins DR, Khoury H, Curtin P, Hurd D, et al (2001) Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 98(2):266\u2013271","journal-title":"Blood"},{"key":"749_CR15","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1046\/j.1365-2133.1999.03213.x","volume":"141","author":"Bartolome","year":"1999","unstructured":"Bartolome B, Cordoba S, Nieto S, Fernandez-Herrera J, Garcia-Diez A (1999) Acute arsenic poisoning: clinical and histopathological features. Br J Dermatol 141(6):1106\u20131109","journal-title":"Br J Dermatol"},{"key":"749_CR16","first-page":"406","volume":"3","author":"Serrano","year":"1911","unstructured":"Serrano M, Sainz de Aja E (1911) Zonas y herpes como efectos de la medicacion por salvarsan. Actas Dermosifiliograf 3:406\u2013409","journal-title":"Actas Dermosifiliograf"},{"key":"749_CR17","unstructured":"Package insert (2001) Trisenox (arsenic trioxide). Cell Therapeutics, Seattle, WA"},{"key":"749_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/blood.V97.1.264","volume":"97","author":"Jing","year":"2001","unstructured":"Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH, et al (2001) Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97(1):264\u2013269","journal-title":"Blood"},{"issue":"Suppl 1","key":"749_CR19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/shem.2002.33611","volume":"39","author":"Z Chen","year":"2002","unstructured":"Chen Z, Chen GQ, Shen ZX, Sun GL, Tong JH, Wang ZY, et al (2002) Expanding the use of arsenic trioxide: leukemias and beyond. Semin Hematol 39[Suppl\u00a01]: 22\u201326","journal-title":"Semin Hematol"},{"key":"749_CR20","doi-asserted-by":"crossref","unstructured":"Murgo AJ (2001) Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies. Oncologist 6[Suppl\u00a02]: 22\u201328","DOI":"10.1634\/theoncologist.6-suppl_2-22"},{"key":"749_CR21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.99.4.608","volume":"99","author":"Christian","year":"1997","unstructured":"Christian CW, Singer ML, Crawford JE, Durbin D (1997) Perianal herpes zoster presenting as suspected child abuse. Pediatrics 99(4):608\u2013610","journal-title":"Pediatrics"},{"key":"749_CR22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1590\/S0066-782X2000001200006","volume":"75","author":"Franken","year":"2000","unstructured":"Franken RA, Franken M (2000) Pseudo-myocardial infarction during an episode of herpes zoster. Arq Bras Cardiol 75(6):523\u2013530","journal-title":"Arq Bras Cardiol"},{"key":"749_CR23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","volume":"123","author":"Tyring","year":"1995","unstructured":"Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al (1995) Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123(2):89\u201396","journal-title":"Ann Intern Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-003-0749-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0749-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-003-0749-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:28:48Z","timestamp":1659043728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-003-0749-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,8]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s00277-003-0749-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,8]]},"assertion":[{"value":"1 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}